Closed Solicitation · DEPARTMENT OF VETERANS AFFAIRS
AI Summary
The Department of Veterans Affairs intends to award a sole source task order to Progenics Pharmaceuticals, Inc. for PYLARIFY® (piflufolastat F 18) Injections. This procurement is for unit dose syringes of F-18 Piflufolastat for PET imaging, essential for diagnosing various pathologies. Interested parties may express their capability to meet this requirement by February 4, 2026.
INTENT TO SOLE SOURCE THIS IS NOT A SOLICITATION OR REQUEST FOR OFFERS. NO SOLICITATION PACKAGE IS AVAILABLE NOR WILL TELEPHONE REQUESTS BE HONORED. NO SOLICITATION WILL BE POSTED TO CONTRACT OPPORTUNITIES. PROCUREMENT TITLE: Pylarify Radiopharmaceuticals INTENT TO AWARD: The Department of Veterans Affairs (NCO 19), 6162 S. Willow Drive, Greenwood Village, CO 80111, intends to award one (1) task order on a sole source basis, to Progenics Pharmaceuticals, Inc., for PYLARIFY® (piflufolastat F 18) Injections. BACKGROUND AND DESCRIPTION: This procurement is for the continued providing of unit dose syringes of F-18 Piflufolastat (Pylarify) for positron emitting tomography (PET) imaging as ordered by the Nuclear Medicine Department. Pylarify is a radiopharmaceutical, or medicinal radio-compound, and contains radioactive isotopes. Radiopharmaceuticals can be used as diagnostic and therapeutic agents to diagnose specific pathologies, such as cancer, osteomyelitis, cardiac ischemia, and infection. NAICS: 325412 Pharmaceutical Preparation Manufacturing, $34 Million PSC: 6505 Drugs and Biologicals AUTHORITY: This procurement will be issued under the authority of FAR Part 8 Required Sources of Supplies and Services. A determination by the Government not to compete this proposed award upon response to this notice is solely within the discretion of the Contracting Officer. INTERESTED PARTIES: THIS NOTICE OF INTENT IS NOT A REQUEST FOR COMPETITIVE QUOTES. Interested parties may identify their interest and capability to respond to this requirement as described in the attached Statement of Work no later than 3:00 PM Mountain Standard Time, Wednesday, February 4th, 2026. Information received in response to this notice must clearly demonstrate the capability of meeting the Government s need as stated above. Include any relevant information (specifications, cut sheets, brochures, capability statement, etc.) confirming the ability to supply the products and/or any services outlined in this notice. Responses to this notice are to be sent to heather.chase2@va.gov. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. The Government is not responsible for any potential costs incurred from interested parties desiring to respond to this notice. ATTACHED: Statement of Work
6505--NOTICE OF INTENT TO SOLE SOURCE F-18 PIFLUFOLASTAT (PYLARIFY FOR THE GEORGE E. WAHLEN VA MEDICAL CENTER IN SALT LAKE CITY, UTAH. is a federal acquisition solicitation issued by DEPARTMENT OF VETERANS AFFAIRS. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.
SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.